BKCYF yields 7.19% · PFE yields 6.13%● Live data
📍 BKCYF pulled ahead of the other in Year 1
Combined, BKCYF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BKCYF + PFE for your $10,000?
Bank of Cyprus Holdings Public Limited Company, through its subsidiaries, provides banking, financial, and insurance services. It offers current, savings, notice, instant access, and fixed deposits; housing, student, consumer, business and business premises, term, and home or investment loans; and asset finance, factoring, trade facilities, European financial, project finance, shipping finance, and syndicated and corporate lending services, as well as hire purchase services for car and equipment. The company also provides debit, credit, prepaid, and special cards; reward programs; digital products; digital banking, and payments and services; motor, home, business, life, create capital, and health insurance products; SME guarantee facility services; day to day banking services; investment banking and brokerage, asset and wealth management, market execution and hedging, and structured and funding solutions; investment products and services; and custody and depositary services. In addition, it is involved in the property trading and development activities; land development and operation of a golf resort; management administration and safekeeping of UCITS units; administration of guarantees and holding of real estate properties; collection of the existing portfolio of receivables, including third party collections; and provision of card processing transaction, auction, and secretarial services. As of June 30, 2022, the company operated 86 branches in Cyprus. Bank of Cyprus Holdings Public Limited Company was founded in 1899 and is headquartered in Nicosia, Cyprus.
Full BKCYF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.